The National Healthcare Quality and Disparities Reports have moved to the new AHRQ Data Tools site. After June 30, 2022, this web page will no longer be available.

WisconsinHealthy Living Quality Measures Compared to Achievable Benchmarks

The NHQDR quality measures specific to Healthy Living are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For example, low values are desirable for measures such as infant mortality, whereas high values are desirable for measures such as preventative screening. The categories of achievement have been standardized across the measure definitions so that:

 
Far away from benchmark - a State's value for a measure has not achieved 50% of the benchmark.
 
Close to benchmark - a State's value for a measure is between 50% and 90% of a benchmark (i.e., worse than the benchmark but has achieved at least half of the benchmark but not as much as 90% of a benchmark).
 
Achieved benchmark or better - a State's value for a measure is no worse than 90% of the benchmark value, the measure has achieved the benchmark. This category also includes the case in which the measure’s value is equal to or better than the benchmark.
Measures That Achieved Benchmark or Better
Measure Estimate Benchmark Distance to Benchmark
Long-stay nursing home residents with physical restraints 0.2 0.3 Achieved: 30% better
Adults ages 18-64 at high risk (e.g., COPD) who ever received pneumococcal vaccination 47.9 44.8 Achieved: 7% better
Home health care patients whose ability to get in and out of bed improved 75.7 72.6 Achieved: 4% better
Home health patients who had influenza vaccination during flu season 97.8 94.1 Achieved: 4% better
Home health care patients whose pain when moving around decreased 77.8 75.1 Achieved: 4% better
Home health care patients whose ability to walk or move around improved 75.9 74.2 Achieved: 2% better
Adults age 65 and over who ever received pneumococcal vaccination 79.7 78.7 Achieved: 1% better
Adults who received a blood cholesterol measurement in the last 5 years 82.9 82.3 Achieved: 1% better
Home health patients who had pneumococcal polysaccharide vaccination 91.7 91.0 Achieved: 1% better
Home health care patients whose shortness of breath decreased 78.5 78.4 -0.1%
Home health patients who had improvement in upper body dressing 79.0 79.3 0.3%
Women ages 21-65 who received a Pap smear in the last 3 years 83.7 84.2 0.6%
Long-stay nursing home residents who were assessed for pneumococcal vaccination 96.2 97.0 0.9%
Long-stay nursing home patients who were assessed and appropriately given the seasonal influenza vaccine 92.6 93.9 1.4%
Hospital patients who received influenza vaccination 95.1 96.6 1.6%
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 94.4 95.9 1.6%
Short-stay nursing home residents who were assessed for pneumococcal vaccination 89.4 91.4 2.1%
Home health care patients who stayed at home after an episode of home health care 83.5 85.5 2.4%
Home health care patients whose bathing improved 76.3 78.2 2.4%
Short-stay nursing home patients who had flu vaccination appropriately given 89.8 92.2 2.6%
Home health patients who had improvement in toileting 76.8 78.9 2.7%
Women ages 50-74 who received a mammogram in the last 2 years 80.3 84.7 5.2%
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 90.3 96.4 6.3%
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine 89.9 96.4 6.7%
Children ages 19-35 months who received 3 or more doses of polio vaccine 89.7 97.3 7.8%
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine 88.3 96.2 8.2%
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years 87.4 95.2 8.2%
Children ages 19-35 months who received 1 or more doses of varicella vaccine 87.1 95.7 9.0%
Measures That Are Close to Benchmark
Measure Estimate Benchmark Distance to Benchmark
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine 81.1 90.6 10.5%
Infants born in the calendar year who received breastfeeding exclusively through 3 months 55.8 63.6 12.2%
Adults ages 18-64 at high risk (e.g., COPD) who received an influenza vaccination in the last flu season 41.4 47.8 13.4%
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine 80.7 95.4 15.4%
Low-risk, long-stay nursing home residents with loss of control of bowels or bladder 72.8 63.0 15.6%
Long-stay nursing home residents whose need for help with daily activities increased 20.3 17.1 18.9%
Long-stay nursing home residents with too much weight loss 5.7 4.7 21.0%
Long-stay nursing home residents whose ability to move independently worsened 25.3 20.7 22.2%
Breast cancer diagnosed at advanced stage (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and over 91.7 73.8 24.3%
Adults age 65 and over who received an influenza vaccination in the last flu season 53.2 70.3 24.3%
Cervical cancer diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 9.7 7.7 25.6%
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional or distant stage) per 100,000 population age 50 and over 64.8 48.6 33.3%
Measures That Are Far From Benchmark
Measure Estimate Benchmark Distance to Benchmark
Short-stay nursing home residents with moderate to severe pain 16.4 10.5 56.2%
Long-stay nursing home residents with moderate to severe pain 9.5 4.3 120.3%
Measures With No Available Benchmark Information
Measure Estimate Benchmark Distance to Benchmark
Adolescents females ages 16-17 who received 3 or more doses human papillomavirus vaccine